Navigation Links
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
Date:12/6/2007

New Product Name Also Unveiled in Ongoing Preparation for Commercial Launch

SAN DIEGO, Dec. 6 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, announced that new data, including four-year follow-up data from the Company's Phase 2 clinical trial of Specifid(TM) (formerly FavId(R)), will be reported in four separate poster presentations at the American Society of Hematology (ASH) Annual Meeting, which begins Saturday in Atlanta.

On Sunday, Dr. Omer Koc of the Cleveland Clinic will present long-term follow-up data from an 89-patient Phase 2 clinical trial of Specifid following Rituxan(R) treatment. The data suggest that the administration of Specifid following Rituxan may extend progression-free survival in patients with follicular B-cell non-Hodgkin's lymphoma (NHL) compared to historical data of Rituxan alone. In particular, 40% of the treatment-naive patients in the trial (n=35) remain progression-free at four years, compared to the published literature, which shows that approximately 20% of patients treated with Rituxan alone were progression-free at three years. Most adverse events reported in the trial were of low grade, the most common of which was injection site reaction.

Dr. Koc will present a second poster on Monday investigating patients treated with Specifid following Rituxan who achieved a complete remission during this Phase 2 trial. Of the 18 patients in complete remission (nine treatment-naive and nine relapsed from or refractory to prior therapy), only six have progressed to date and one withdrew from the trial while in complete remission. The 11 remaining patients continue to be disease-free four to five years from the start of Rituxan. In addition, 16 of the patients who achieved a complete remission did so during the Specifid phase of the trial and converted as late as 33 months from the start of Rituxan.

<
'/>"/>
SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Even the hot Texas sun won’t keep ... . The school had previously invested in a ... from APCPLAY, but recently asked for an innovative solution to ... Godley Elementary School chose a Rectangular Shade from APCPLAY as ... on their playground. The shade measures 24’W x 34’H ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Based in ... care to residents of Brazoria County and surrounding counties. ... the clinic is now accessible from Northbound Highway 288 ... a center where patients can get low-cost urgent care ... far from rare, finding places that can match the ...
(Date:7/10/2014)... 2014 Fatigue, lack of safety ... number of accidents in the workplace, according to ... articles highlight safety issues that contribute to the ... occur on the job annually, according to the ... explore "preventable workplace accidents." , Safety Issue: "Extended ...
(Date:7/10/2014)... 2014 According to a new ... Platforms (Land, Airborne, Naval), Application (Software Defined Radios, ... Geography (North America, Asia-Pacific, Europe, the Middle East ... by MarketsandMarkets, the market is estimated to be ... register a CAGR of 5.56% to reach $39.52 ...
(Date:7/10/2014)... 2014 Parker Waichman LLP, a ... of victims injured by defective medical devices, reports ... allegations that the woman’s hidden, aggressive leiomyosarcoma was ... used during a routine laparoscopic supracervical hysterectomy procedure. ... Medical Instruments Corporation over its Wolf Power Morcellator ...
Breaking Medicine News(10 mins):Health News:Cool Fun Under the Texas Sun: Godley Elementary School Purchases Shade Structure from APCPLAY© 2Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 2Health News:Safety Reboot Magazine Focuses on: Why Extended Hours is Dangerous in the Workplace; Why Custodial Work Can be Dangerous; and Improving Safety for Roofers 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 3Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 5
... , This release is available in Spanish ... have a powerful effect on formation of strong, healthy bones, ... hold true for humans. Jin-Ran Chen and his ... U.S. Department of Agriculture (USDA) at the Arkansas Children,s Nutrition ...
... tsunamis to war and genocide which wreak devastation on millions ... from the headlines. But how do policymakers, charities and medics ... influences their tactics and the style of humanitarian aid? ... London School of Hygiene & Tropical Medicine, with Boris Martin, ...
... In the 1983 movie "A Man with Two Brains," Steve Martin ... two brains inside his own skull as we all do, ... it comes to seeing the world around us, each of our ... working memory. Normally, it takes years or decades after a ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... increasingly popular, inflatable models, pose serious risks to young children, ... Children,s Hospital in Columbus, Ohio, detail the drowning deaths of ... a variety of above-ground pools, some large and deep, others ...
... substitutes used in low-calorie potato chips and other foods ... according to a study published by the American Psychological ... challenges the conventional wisdom that foods made with fat ... fat substitutes can interfere with the body,s ability to ...
... of medicine and community health sciences at Boston University ... Institute on Drug Abuse (NIDA) International Program 2011 Awards ... and investment in mentoring scientists in their pursuits in ... who is also chief of the Section of General ...
Cached Medicine News:Health News:Blueberries help lab rats build strong bones 2Health News:New book shines light on French versus British models of humanitarian aid 2Health News:Picower: 1 skull + 2 brains = 4 objects in mind 2Health News:Picower: 1 skull + 2 brains = 4 objects in mind 3Health News:Portable Pools Pose Drowning Risk for Young Kids 2Health News:Portable Pools Pose Drowning Risk for Young Kids 3Health News:Fat substitutes linked to weight gain 2Health News:BU'S Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner 2
(Date:7/10/2014)... 2014  Decision Resources Group finds that while ... specialists are willing to prescribe Durata,s Dalvance (dalbavancin) ... as OPAT, approximately two-thirds of the respondents reported ... hospital inpatients. However, our findings indicate that nearly ... on OPAT following hospital discharge, and most are ...
(Date:1/15/2014)... , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds ... its store . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ... upgrade and policy support, China,s ... years, with total market size rising from 3.28 billion ...
(Date:1/15/2014)... Jan. 15, 2014  Novation, the leading health care supply ... IT value-added reseller (VAR) national contracts that expand its ... services at lower costs. These include manufacturer product and ... initiative assistance and ongoing IT consulting support. ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2
... April 9, 2008 Dutch biotechnology,company Crucell N.V., ... South,African Tuberculosis Vaccine Initiative (SATVI) present a progress ... tuberculosis vaccine study at the,biennial "Tuberculosis Vaccines for ... today. The study, conducted in Worcester, South,Africa and ...
... NEW YORK, April 9, 2008 Intra-Cellular ... its ongoing development,programs for ITI-007, the Company,s ... (DPPM), and ITI-722,a low-dose formulation of ITI-007, ... disorders, respectively. These new data demonstrate,ITI-007 has ...
Cached Medicine Technology:Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: